We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Presents Total PCR Solution at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023
Print article
Image: BioPerfectus is attending Medlab Middle East 2023 (Photo courtesy of BioPerfectus)
Image: BioPerfectus is attending Medlab Middle East 2023 (Photo courtesy of BioPerfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is presenting its Total PCR Solution at Medlab Middle East 2023 that can improve operational and cost efficiency, optimize workflow, and increase performance at every opportunity.

Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. These products could cover PCR detection workflow and assure the users with reassuring results by validated performance. At Medlab Middle East 2023, Bioperfectus is highlighting the STC-96A Plus Real-Time PCR system that is a more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. Bioperfectus is also highlighting the SAW-96 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that integrates cutting-edge mechanical, electronic, and software technologies. In addition, Bioperfectus is showcasing the SSNP-2000B nucleic acid extraction system, which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction of 32 samples maximum in one time.

Among its other nucleic acid extraction solutions, Bioperfectus is highlighting the SMPE-960 nucleic acid extraction system which integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Bioperfectus is also providing a glimpse of its new products to be launched soon, including the SSNP-A6 nucleic acid extraction system that can extract nucleic acids from 96 samples simultaneously to meet the requirement for high throughput laboratories, alongside the SSP-1196 automatic sample preparing system that enables automated capping, scanning of barcode, transfer of sample liquid to the extraction plate, decapping and ready to extraction.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Benchtop Cooler
PCR-Cooler & PCR-Rack

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.